Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
SRPT
SRPT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SRPT News
Sarepta Therapeutics to Report Q4 and Full-Year 2025 Financial Results
4d ago
Newsfilter
Sarepta Therapeutics Set to Release Financial Results for Q4 and Full Year 2025
4d ago
moomoo
Sarepta Receives Approval for SRP-1005 Clinical Trial in New Zealand
Feb 04 2026
Newsfilter
Analysis of Risks and Returns in Selling SRPT Options
Jan 30 2026
NASDAQ.COM
U.S. Natural Gas Prices Surge Over 30% Amid Winter Storm
Jan 26 2026
Benzinga
Sarepta Therapeutics Reports Significant Three-Year Study Results
Jan 26 2026
Benzinga
Significant Stock Movements for Multiple Companies
Jan 26 2026
CNBC
Nvidia Invests Additional $2 Billion in CoreWeave for AI Factories
Jan 26 2026
Yahoo Finance
Sarepta Reports Three-Year Efficacy Data for Elevidys in Duchenne Muscular Dystrophy
Jan 26 2026
Benzinga
Sarepta Reports Positive Three-Year Results for Elevidys in DMD
Jan 26 2026
seekingalpha
Sarepta Therapeutics Reports Positive Three-Year EMBARK Study Results for ELEVIDYS
Jan 26 2026
stocktwits
Sarepta Shares Rise as 3-Year Elevidys Study Results Offer Promise.
Jan 26 2026
Barron's
Sarepta Shares Climb Following Encouraging Three-Year Study Findings for Elevidys
Jan 26 2026
Barron's
Sarepta to Report EMBARK Study Results
Jan 26 2026
NASDAQ.COM
U.S. Stock Futures Decline as Investors Await Earnings Reports
Jan 26 2026
Benzinga
Stock Market Movers: USA Rare Earth, Micron, Intel, AMD, Newmont, RevMed, and Others
Jan 26 2026
Barron's
Show More News
